Clinical Evaluation of a New Antigen-Based COVID-19 Rapid Diagnostic Test from Symptomatic Patients

Accurate diagnosis at the right moment is the prerequisite for treatment of any disease. Failure to correctly diagnose a disease can result in highly detrimental effects, unmistakably a crucial factor during the COVID-19 pandemic. RT-PCR is the gold standard for COVID-19 detection while there are other test procedures available, such as LAMP, X-Ray, and ELISA. However, these tests are expensive, require sophisticated equipment and a highly trained workforce, and multiple hours or even days are often required to obtain the test results. A rapid and cheap detection system can thus render a solution to the screening system on a larger scale and be added as an aid to the current detection processes. Recently, some rapid antigen-based COVID-19 tests devices have been developed and commercialized. In this study, we evaluated the clinical performance of a new rapid detection device (OnSite® COVID-19 Ag Rapid Test by CTK Biotech Inc., Poway, CA, USA) on COVID-19 symptomatic patients (n = 380). The overall sensitivity and specificity were 91.0% (95% CI: 84.8–95.3%) and 99.2% (95% CI: 97.1–99.9), against gold standard RT-PCR. The kit was capable of detecting patients even after 06 days of onset of symptoms and the sensitivity can be maximized to 98% in samples with an average RT-PCR Ct ≤ 26.48, demonstrating a high potential of the kit for clinical diagnosis of symptomatic patients in healthcare facilities.

[1]  M. Garcia-Bereguiain,et al.  Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CDC EUA as a Quality Control Proxy for Developing Countries , 2021, Frontiers in Cellular and Infection Microbiology.

[2]  P. Karakousis,et al.  Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions , 2021, BMC Infectious Diseases.

[3]  K. Alkharsah Laboratory tests for the detection of SARS-CoV-2 infection: basic principles and examples , 2021, German medical science : GMS e-journal.

[4]  B. D. Malhotra,et al.  Point-of-Care PCR Assays for COVID-19 Detection , 2021, Biosensors.

[5]  H. Nakaya,et al.  Colorimetric RT-LAMP SARS-CoV-2 diagnostic sensitivity relies on color interpretation and viral load , 2021, Scientific Reports.

[6]  David A. Drew,et al.  Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study , 2021, The Lancet Infectious Diseases.

[7]  P. Meybohm,et al.  Ivermectin for preventing and treating COVID‐19 , 2021, The Cochrane database of systematic reviews.

[8]  D. Spandidos,et al.  Current and innovative methods for the diagnosis of COVID-19 infection (Review) , 2021, International journal of molecular medicine.

[9]  L. Pirofski,et al.  Understanding vaccine hesitancy in COVID-19 , 2021, Med.

[10]  Mi-Kyung Lee,et al.  Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients , 2021, PloS one.

[11]  H. Gendelman,et al.  Diagnostics for SARS-CoV-2 infections , 2021, Nature Materials.

[12]  M. Jit,et al.  Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment , 2021, The Lancet.

[13]  T. Vittorio,et al.  Current treatment in COVID-19 disease: a rapid review , 2021, Drugs in context.

[14]  R. Almaghrabi,et al.  Controlling COVID-19 Pandemic: A Mass Screening Experience in Saudi Arabia , 2021, Frontiers in Public Health.

[15]  E. Albert,et al.  Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients , 2021, Clinical Microbiology and Infection.

[16]  Gannon C.K. Mak,et al.  Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2 , 2020, Journal of Clinical Virology.

[17]  U. Saeed,et al.  Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy , 2020, Virology journal.

[18]  A. Gayet-Ageron,et al.  Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers , 2020, medRxiv.

[19]  E. Albert,et al.  Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres , 2020, Clinical Microbiology and Infection.

[20]  A. Mishra,et al.  COVID-19 infection: Disease detection and mobile technology , 2020, PeerJ.

[21]  Meral Yüce,et al.  COVID-19 diagnosis —A review of current methods , 2020, Biosensors and Bioelectronics.

[22]  F. Cerutti,et al.  Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 , 2020, Journal of Clinical Virology.

[23]  P. Kremsner,et al.  Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible , 2020, International Journal of Infectious Diseases.

[24]  Yanxi Han,et al.  COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission , 2020, International journal of biological sciences.

[25]  J. Quick nCoV-2019 sequencing protocol v3 (LoCost) , 2020 .

[26]  H. Sung,et al.  Evaluation of Four Commercial Kits for SARS-CoV-2 Real-Time Reverse-Transcription Polymerase Chain Reaction Approved by Emergency-Use-Authorization in Korea , 2020, Frontiers in Medicine.

[27]  Kevin Yap,et al.  Mobile Health Apps That Help With COVID-19 Management: Scoping Review , 2020, JMIR nursing.

[28]  F. Downes,et al.  Identification of SARS-CoV-2 in a Proficiency Testing Program , 2020, American journal of clinical pathology.

[29]  M. C. Muenker,et al.  Detection of SARS-CoV-2 RNA by multiplex RT-qPCR , 2020, bioRxiv.

[30]  Gannon C.K. Mak,et al.  Evaluation of rapid antigen test for detection of SARS-CoV-2 virus , 2020, Journal of Clinical Virology.

[31]  E. Righi,et al.  Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities , 2020, Cureus.

[32]  S. Scarlata,et al.  COVID‐19 diagnosis and management: a comprehensive review , 2020, Journal of internal medicine.

[33]  K. Lokuge,et al.  Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission , 2020, BMC Medicine.

[34]  Victor M. Montori,et al.  COVID-19 Testing , 2020, Mayo Clinic Proceedings.

[35]  Ioannis D. Apostolopoulos,et al.  Covid-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks , 2020, Physical and Engineering Sciences in Medicine.

[36]  Trevor Bedford,et al.  Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.